Rhode Island House Bill H7756

Rhode Island 2026 Regular Session

• Introduced: 2/12/26
• Refer: 2/12/26

Caption

Amends current law on controlled substances to permit psilocybin to be cultivated within a person's residence for personal use and contingent on the US FDA's program, mandate that RI department of health establish rules regulations.

Impact

The enactment of H7756 is contingent upon the rescheduling of psilocybin by the U.S. Food and Drug Administration (FDA). If approved, the Rhode Island Department of Health will be required to establish regulations governing cultivation, distribution, and medical prescription of psilocybin. This could significantly alter the legal landscape around mental health treatments in the state, potentially providing new avenues for patients while also imposing certain regulations on its cultivation and use.

Summary

House Bill H7756, introduced in 2026, aims to amend the current law on controlled substances in Rhode Island by allowing the secure cultivation of psilocybin within a person's residence for personal use. The bill specifically excludes up to one ounce of psilocybin from the provisions of the Uniform Controlled Substances Act, provided it is cultivated or shared between individuals under specified conditions. This change reflects a growing trend toward improving access to psilocybin, particularly for individuals dealing with serious mental or behavioral health disorders.

Contention

Notable points of contention surrounding H7756 involve discussions about the implications of legalizing psilocybin use and its impact on public health and safety. Supporters argue that this bill could improve mental health treatment options, especially for those without access to effective medications. Critics, however, may raise concerns regarding the risks of misuse and the standards for cultivation and distribution, emphasizing the need for robust regulatory frameworks to prevent abuse.